Healthcare >> CEO Interviews >> December 18, 2000
David P. Summers, PhD, MBA, FACA, is Chief Executive Officer and
Chairman of the Board for Endovasc. Dr. Summer is a Fellow in the
American College of Angiology, Fellow in the International Society for
Endovascular Surgery, and a businessman/scientist. He has invented a
number of highly sophisticated drug delivery and minimally invasive
medical devices used primarily to treat cardiovascular diseases. He is
the author of 26 issued patents and has four patents pending. Dr.
Summers founded American BioMed, Inc. (ABMI), a NASDAQ public company in
1984 and served as its President and CEO until June 1995. Prior to
founding ABMI, he was employed in various senior marketing and
management positions with C. R. Bard, Inc. (manufacturer and distributor
of cardiovascular medical products), Karl Stortz Endoscopy (an
endoscopic instrument company), and Pall Corporation (a manufacturer and
distributor of blood filtration products for medical use). An
engineer/inventor with over 30 years experience in drug delivery and
medical device design and development, Dr. Summers went on to receive an
MBA in 1989 from Pepperdine University (Malibu, California), then
received a doctorate in 1992 in International Business and Economics at
Kennedy-Western University (Boise, Idaho). He holds additional
memberships in the New York Academy of Sciences, American Association of
Internal Artificial Organs (ASIAO), American College of Physician
Inventors, American Association for Advancement of Science (AAAS),
Houston Inventors Association, European Vascular Society, and is a
Senior Member of the Society of Plastic Engineers. Profile
Ltd.?
Dr. Summers: Endovasc is a direct enhancer of drug delivery. Endovasc
takes generic, already approved drugs and
